Stop the Bleeding: Can Gene Therapy Finally Cure Hemophilia? - Xconomy

/

http://ift.tt/1HncR2Y Click to read full article...

Stop the Bleeding: Can Gene Therapy Finally Cure Hemophilia?XconomyBen Haugstad is 12 years old and loves Taekwondo. He's been doing it for six years, and soon he'll be a black belt. He also has a severe form of hemophilia. His body doesn't produce the machinery needed to clot blood, and at any moment a bad tumble or ...

from Hemophilia - Google News http://ift.tt/1HncR2Y via IFTTT

Adult hemophiliacs can now get treatment in Austin - KVUE

/

http://ift.tt/1HpUU7j Click to read full article...

KVUE

Adult hemophiliacs can now get treatment in AustinKVUERick, who was living in California at the time, was treated by physicians trained in adult hemophilia. That would not have been possible in Austin then, but it is now. Texas Oncology has opened the first adult hemophilia treatment program in Central ...

from Hemophilia - Google News http://ift.tt/1HpUU7j via IFTTT

ABC's Secrets and Lies insults bleeding disorders community - Bangor Daily News (blog)

/

http://ift.tt/1FFtxVe Click to read full article...

ABC's Secrets and Lies insults bleeding disorders communityBangor Daily News (blog)hemophilia When I tell people that my son has hemophilia I tend to hear the same kinds of questions. Is he related to a Russian Czar? No, he isn't. Will he grow out of it? No, he won't. Can you bubble wrap him? No, but the thought has certainly crossed ...

from Hemophilia - Google News http://ift.tt/1FFtxVe via IFTTT

Novel Approaches for Hemophilia Treatment - Medscape

/

http://ift.tt/1FJAnZr Click to read full article...

Medscape

Novel Approaches for Hemophilia TreatmentMedscapeHemophilia is a genetic disease caused by mutation of one of the genes for coagulation proteins. When severe (defined as clotting activity < 1%), patients are at risk for spontaneous, life-threatening bleeding episodes. Individuals with moderate ...

from Hemophilia - Google News http://ift.tt/1FJAnZr via IFTTT

Joint aspiration safe in children with acute hemarthrosis, severe hemophilia A - Healio

/

http://ift.tt/1GXtQZv Click to read full article...

Joint aspiration safe in children with acute hemarthrosis, severe hemophilia AHealioDuring an 11-year study period, boys in Western Australia with severe hemophilia A and acute hemarthrosis safely had joint aspiration to avoid joint damage, according to recently published research.

from Hemophilia - Google News http://ift.tt/1GXtQZv via IFTTT

Joint aspiration safe in children with acute hemarthrosis, severe hemophilia A - Healio

/

http://ift.tt/1AYiC2j Click to read full article...

Joint aspiration safe in children with acute hemarthrosis, severe hemophilia AHealioDuring an 11-year study period, boys in Western Australia with severe hemophilia A and acute hemarthrosis safely had joint aspiration to avoid joint damage, according to recently published research.and more »

from Hemophilia - Google News http://ift.tt/1AYiC2j via IFTTT

Baxters BAX 817 Tests Positive for Hemophilia Treatment - Zacks.com

/

http://ift.tt/1wWyOpt Click to read full article...

Baxters BAX 817 Tests Positive for Hemophilia TreatmentZacks.comBaxter International Inc. (BAX - Analyst Report) recently revealed positive efficacy and safety data from its Phase III clinical trial evaluating BAX 817 – an investigational recombinant factor VIIa (rFVIIa) for hemophilia A or B patients who develop ...Baxter International Inc. (NYSE:BAX) on Watch ListMarkets WiredLarge Cap Stocks in the Spotlight - Baxter International (BAX), Colgate ...Techsonian (press release)all 4 news articles »

from Hemophilia - Google News http://ift.tt/1wWyOpt via IFTTT

Drug companies developing longer-acting clotting agents for hemophiliacs - BABW News

/

http://ift.tt/1Frvzrt Click to read full article...

BABW News

Drug companies developing longer-acting clotting agents for hemophiliacsBABW NewsSeveral drug companies, such as Biogen Idec and Novo Nordisk, are developing new, longer-acting versions of the blood clotting factors used by people with hemophilia. Patients with severe forms of the disease need regular infusions, lasting 30 minutes ...

from Hemophilia - Google News http://ift.tt/1Frvzrt via IFTTT

New Gene Therapy for Hemophilia Shows Potential as Safe Treatment - Bioscience Technology

/

http://ift.tt/18y8gja Click to read full article...

Bioscience Technology

New Gene Therapy for Hemophilia Shows Potential as Safe TreatmentBioscience TechnologySource: Max Englund/UNC School of Medicine A multi-year, ongoing study suggests that a new kind of gene therapy for hemophilia B could be safe and effective for human patients. Published in the journal Science Translational Medicine, the research ...

from Hemophilia - Google News http://ift.tt/18y8gja via IFTTT

Public Health Spreads Awareness of Hemophilia - Pacific News Center

/

http://ift.tt/1BM3qdy Click to read full article...

Public Health Spreads Awareness of HemophiliaPacific News CenterOn Friday the Department of Public Health and Social Services Guam comprehensive Hemophilia care program under the Bureau of Community Health Services sponsored a hemophilia conference in celebration of hemophilia awareness month. This year's ...and more »

from Hemophilia - Google News http://ift.tt/1BM3qdy via IFTTT

Public Health Spreads Awareness of Hemophilia - Pacific News Center

/

http://ift.tt/1LhS33i Click to read full article...

Public Health Spreads Awareness of HemophiliaPacific News CenterOn Friday the Department of Public Health and Social Services Guam comprehensive Hemophilia care program under the Bureau of Community Health Services sponsored a hemophilia conference in celebration of hemophilia awareness month. This year's ...and more »

from Hemophilia - Google News http://ift.tt/1LhS33i via IFTTT

Mutant protein brings gene therapy for hemophilia a step closer - Medical News Today

/

http://ift.tt/1BH4e3m Click to read full article...

Medical News Today

Mutant protein brings gene therapy for hemophilia a step closerMedical News TodayHemophilia is an inherited condition caused by a mutation in a gene responsible for producing proteins in the blood needed for normal blood clotting, called clotting factors. As a result, people with hemophilia are prone to internal bleeding ...

from Hemophilia - Google News http://ift.tt/1BH4e3m via IFTTT

Clinicians Test New Strategies for Hemophilia Treatment - Medscape

/

http://ift.tt/1BC9EMU Click to read full article...

Clinicians Test New Strategies for Hemophilia TreatmentMedscapeHemophilia A and B are congenital bleeding disorders caused by insufficient thrombin generation. Hemophilia A is due to a deficiency in factor VIII; hemophilia B is due to a deficiency in factor IX. In the presence of normal levels of endogenous ...and more »

from Hemophilia - Google News http://ift.tt/1BC9EMU via IFTTT

Clinicians Test New Strategies for Hemophilia Treatment - Medscape

/

http://ift.tt/1AvpjZw Click to read full article...

Clinicians Test New Strategies for Hemophilia TreatmentMedscapeHemophilia A and B are congenital bleeding disorders caused by insufficient thrombin generation. Hemophilia A is due to a deficiency in factor VIII; hemophilia B is due to a deficiency in factor IX. In the presence of normal levels of endogenous ...and more »

from Hemophilia - Google News http://ift.tt/1AvpjZw via IFTTT

Baxter's latest hemophilia drug comes through in Phase III - FierceBiotech

/

http://ift.tt/1FYA6zZ Click to read full article...

Baxter's latest hemophilia drug comes through in Phase IIIFierceBiotechThe drug, BAX 817, is designed to replace the missing blood factors that stop blood from clotting normally and cause hemophilia. Many hemophilia patients come to develop inhibitors of such factor-replacement therapies, and Baxter's latest treatment is ...Baxter BioScience Announces Positive Phase III Results for BAX 817 ...MarketWatchall 6 news articles »

from Hemophilia - Google News http://ift.tt/1FYA6zZ via IFTTT

Baxter BioScience Announces Positive Phase III Results for BAX 817 ... - MarketWatch

/

http://ift.tt/1L6RNnG Click to read full article...

Baxter BioScience Announces Positive Phase III Results for BAX 817 ...MarketWatchThe prospective, open-label, randomized, multicenter trial was designed to assess the safety and efficacy of BAX 817 in male patients ages 12 to 65 with hemophilia A or B with inhibitors over a 6-month period using on-demand therapy. The trial met its ...and more »

from Hemophilia - Google News http://ift.tt/1L6RNnG via IFTTT

Baxter (BAX) Phase III Study of BAX 817 Met Primary Endpoint - StreetInsider.com

/

http://ift.tt/1GMIxC5 Click to read full article...

Baxter (BAX) Phase III Study of BAX 817 Met Primary EndpointStreetInsider.comBaxter International Inc. (NYSE: BAX) today announced positive results from its Phase III clinical trial evaluating the safety and efficacy of BAX 817, an investigational recombinant factor VIIa (rFVIIa) treatment for people with hemophilia A or B who ...Baxter BioScience Announces Positive Phase III Results for BAX 817 ...MarketWatchall 5 news articles »

from Hemophilia - Google News http://ift.tt/1GMIxC5 via IFTTT

Baxter Reports Positive Results From Phase III Clinical Trial In Hemophilia - Nasdaq

/

http://ift.tt/1L6yR8I Click to read full article...

Baxter Reports Positive Results From Phase III Clinical Trial In HemophiliaNasdaqThe prospective, open-label, randomized, multicenter trial was to assess the safety and efficacy of BAX 817 in male patients aged 12 to 65 with hemophilia A or B, with inhibitors over a 6-month period using on-demand therapy. The trial met its primary ...and more »

from Hemophilia - Google News http://ift.tt/1L6yR8I via IFTTT

'Turbocharged' protein holds promise in hemophilia gene therapy - News-Medical.net

/

http://ift.tt/1F7T2he Click to read full article...

'Turbocharged' protein holds promise in hemophilia gene therapyNews-Medical.netUsing gene therapy to produce a mutant human protein with unusually high blood-clotting power, scientists have successfully treated dogs with the bleeding disorder hemophilia, without triggering an unwanted immune response. In addition, the ...One-time dose of gene therapy treats hemophilia BFuturity: Research NewsNew Gene Therapy for Hemophilia Shows Potential as Safe TreatmentNewswise (press release)all 6 news articles »

from Hemophilia - Google News http://ift.tt/1F7T2he via IFTTT

One-time dose of gene therapy treats hemophilia B - Futurity: Research News

/

http://ift.tt/18FYOd7 Click to read full article...

One-time dose of gene therapy treats hemophilia BFuturity: Research NewsResults from an ongoing study suggest a new type of gene therapy can safely treat hemophilia B by using a virus to swap out faulty genes with new clotting (factor IX) genes. Tested in animals, the therapy dramatically decreases spontaneous bleeding and ...Study bolsters 'turbocharged' protein as a promising tool in hemophilia gene ...Medical XpressStudy: New gene therapy safe, effective for patients with hemophilia BNews-Medical.netStudy Bolsters "Turbocharged" Protein as a Promising Tool in Hemophilia Gene ...Newswise (press release)all 5 news articles »

from Hemophilia - Google News http://ift.tt/18FYOd7 via IFTTT